Astrocytoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Fs}} | {{CMG}}; {{AE}} {{Fs}} | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | ==Medical Therapy== | ||
* Post surgical medical therapy is recommended in all patients with astrocytoma tumor. | * Post surgical medical therapy is recommended in all patients with astrocytoma tumor. |
Revision as of 20:37, 10 January 2019
Astrocytoma Microchapters |
Diagnosis |
---|
Treatment |
Case Study |
Astrocytoma medical therapy On the Web |
American Roentgen Ray Society Images of Astrocytoma medical therapy |
Risk calculators and risk factors for Astrocytoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Medical Therapy
- Post surgical medical therapy is recommended in all patients with astrocytoma tumor.
Astrocytoma
- 1 Grade 1 and 2 - Low grade astrocytomas
- 1.1 Wait and see
- 1.2 Radiation therapy
- 1.3 Adjunctive chemotherapy
- 2 Grade 3 - Anaplastic astrocytoma
- 2.1 Radiotherpay+ chemotherapy
- Procarbazine, lomustine, vincristine
- Procarbazine, lomustine, temozolomide
- 2.1 Radiotherpay+ chemotherapy
- 3 Grade 4 - Glioblastoma multiform
- 3.1 Chemotherapy
- 3.1.1 Temozolomide
- 3.2 Bevacizumab
- 3.3 Alternating electric fields
- 3.4 Carmustine polymer wafers
- 3.1 Chemotherapy